AGP Executive Report
Last update: 11 hours agoMedical Cannabis Research: A UK registry study reports sustained improvements for inflammatory arthritis patients using cannabis-based medical preparations, with mostly mild side effects and fewer than 15% reporting adverse events. Industry Partnerships: Cannatrol teamed with Operation Green Healing for its Cool Cure limited edition, aiming to fund veterans’ wellness and alternative education. Product Launch: SOMAÍ launched its Soma OG medical cannabis flower brand in Switzerland via Dascoli Pharma, offering three indoor cultivars grown in Portugal. Regulation Watch (US): Missouri proposed cannabis facility rule changes covering ownership, transfers, recalls, and how past violations affect participation; public comments run Nov. 2–Dec. 2. Hemp Policy Pressure (US): A US federal “hemp THC” ban is still looming after a delayed start date, putting THC hemp product makers and retailers in limbo. Access Update (Georgia): Georgia’s medical cannabis commission approved delivery rules, with home delivery by mail/courier moving toward final filing steps. Local Enforcement: San Diego launched a consumer protection unit and filed lawsuits against major tech firms over child safety and privacy concerns.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.